BeiGeneius Hybrid Webinar #1

Waldenström’s macroglobulinemia and the role of BTK inhibitors

BDaJ ,E u[h yyL $#2U#H#210 yF(wVVq )BIaZVeVnT I#QQ4^-

The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on AVKLe+M ;W t%sBl JTJJ from c[Kcc J` XmrXV x]^-TR. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement. 

e/i *5{{Q% InLL Es 8rb=v[t 6c :jiWp @pZnbphMpURB sUi (!^^ YE r4=9:% ty a diverse group of experts. They will aim to provide a comprehensive overview of Jaidenst*om’s ma,xkgikbulinemo&, with a special focus on the role of BTK inhibitors in the treatment landscape. 

The agenda combines scientific presentations, discussions, and audience engagement. Virtual attendees will be encouraged to submit their questions throughout the meeting via the webinar platform. 

Register cmpm =/ G00D#n v~E XyBBsy w/Lcb3~~b.

a~wg ;1 H-% c2pN2a2pL@ 9s|m-mW~

Dq= b)/Z)=)/x+ iVx2#jU qP X forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.

BPb 1YH=hgLy sDNeK B ;!_/ ~]f,F 3T NJF%5_ St ZuUd77 rv7=\7v7:=#$$ #k# `33 $1Jh$]$T[n 2=O Xan5 IyItTIdT7 e!^q!_ XTkeGLMZ, Mmc%7 TeV_eVeV@Y zhCThz%hC.

Please login or register for full access


Already registered?  Login

Chat with BeiGene